Jun 11, 2020
Regeneron Begins First Clinical Trials of Anti-Viral Antibody Cocktail REGN-COV2 for the Treatment and Prevention of COVID-19
Jun 08, 2020
Regeneron Announces Virtual-Only Format for 2020 Annual Meeting of Shareholders
Jun 01, 2020
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
May 25, 2020
Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5 Billion Stock Repurchase
May 11, 2020
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
Apr 27, 2020
Regeneron and Sanofi Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial of Kevzara® (sarilumab) in Hospitalized COVID-19 Patients
Apr 06, 2020
Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation
Mar 17, 2020
Regeneron Announces Important Advances in Novel COVID-19 Antibody Program
Feb 06, 2020
Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
Feb 04, 2020
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus
Jan 10, 2020
Regeneron to Report Fourth Quarter and Full Year 2019 Financial and Operating Results and Host Conference Call and Webcast on February 6, 2020
Jan 08, 2020
Publication Highlights Regeneron's Costimulatory Bispecific Antibodies, an Emerging Class of Cancer Immunotherapy
Dec 05, 2019
Regeneron Announces Positive Topline Phase 2 Data with Anti-C5 Antibody Pozelimab in Patients with a Rare Blood Disorder
Nov 22, 2019
Regeneron's Yancopoulos Receives Columbia College's Alexander Hamilton Award
Nov 06, 2019
Regeneron to Report Results from CD20xCD3 and BCMAxCD3 Bispecifics and C5 Antibody Programs at ASH Annual meeting
Nov 05, 2019
Regeneron Reports Third Quarter 2019 Financial and Operating Results
Aug 15, 2019
Regeneron Announces Upcoming Investor Conference Presentation
Aug 14, 2019
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
Aug 12, 2019
PALM Ebola Clinical Trial Stopped Early as Regeneron's REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola Deaths
Aug 06, 2019
Regeneron Reports Second Quarter 2019 Financial and Operating Results